#METABOLOMICS WORKBENCH asma_farjallah_20250926_103225 DATATRACK_ID:6495 STUDY_ID:ST004266 ANALYSIS_ID:AN007099 PROJECT_ID:PR002693 VERSION 1 CREATED_ON October 7, 2025, 1:52 pm #PROJECT PR:PROJECT_TITLE UNTARGETED METABOLOMIC AND LIPIDOMIC PROFILING IN CYSTIC FIBROSIS PATIENTS USING PR:PROJECT_TITLE UPLC-QTOF-MS PR:PROJECT_TYPE Untargeted analysis PR:PROJECT_SUMMARY The primary aim of our study is to identify plasma biomarkers in patients with PR:PROJECT_SUMMARY cystic fibrosis through untargeted metabolomic and lipidomic analyses, with the PR:PROJECT_SUMMARY goal of enabling early detection, accurate diagnosis, and effective monitoring PR:PROJECT_SUMMARY of the disease. Liquid chromatography (LC) coupled with time-of-flight mass PR:PROJECT_SUMMARY spectrometry (TOF-MS) was employed to discriminate the 24 cystic fibrosis PR:PROJECT_SUMMARY patients from the 26 age and gender-matched healthy controls. PR:INSTITUTE Université de Sherbrooke PR:DEPARTMENT PEDIATRICS/ Genetics service PR:LABORATORY Centre d’expertise en spectrométrie de masse clinique Waters-CHUS PR:LAST_NAME FARJALLAH PR:FIRST_NAME ASMA PR:ADDRESS 3001, 12e Avenue Nord, Sherbrooke, Québec, Canada PR:EMAIL asma.farjallah@usherbrooke.ca PR:PHONE 8193452671 #STUDY ST:STUDY_TITLE UNTARGETED METABOLOMIC AND LIPIDOMIC PROFILING IN CYSTIC FIBROSIS PATIENTS USING ST:STUDY_TITLE UPLC-QTOF-MS ST:STUDY_SUMMARY The primary aim of our study is to identify plasma biomarkers in patients with ST:STUDY_SUMMARY cystic fibrosis through untargeted metabolomic and lipidomic analyses, with the ST:STUDY_SUMMARY goal of enabling early detection, accurate diagnosis, and effective monitoring ST:STUDY_SUMMARY of the disease. Liquid chromatography (LC) coupled with time-of-flight mass ST:STUDY_SUMMARY spectrometry (TOF-MS) was employed to discriminate the 24 cystic fibrosis ST:STUDY_SUMMARY patients from the 26 age and gender-matched healthy controls. ST:INSTITUTE Université de Sherbrooke ST:DEPARTMENT Pediatrics/Genetics service ST:LABORATORY Centre d’expertise en spectrométrie de masse clinique Waters-CHUS ST:LAST_NAME FARJALLAH ST:FIRST_NAME ASMA ST:ADDRESS 3001, 12e Avenue Nord, Sherbrooke, Québec, Canada ST:EMAIL asma.farjallah@usherbrooke.ca ST:PHONE 8193452671 #SUBJECT SU:SUBJECT_TYPE Human SU:SUBJECT_SPECIES Homo sapiens SU:TAXONOMY_ID 9606 SU:AGE_OR_AGE_RANGE 29-34 SU:GENDER Male and female #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-2 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-2.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-4 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-4.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-5 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-5.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-10 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-10.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-14 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-14.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-15 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-15.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-17 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-17.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-18 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-18.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-19 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-19.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-20 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-20.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-21 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-21.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-22 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-22.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-23 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-23.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-24 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-24.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-26 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-26.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-28 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-28.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-29 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-29.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-30 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-30.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-31 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-31.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-32 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-32.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-33 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-33.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-35 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-35.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-36 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-36.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1-6 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1-6.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_1C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_1C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_2C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_2C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_3C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_3C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_4C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_4C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_5C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_5C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_6C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_6C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_7C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_7C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_8C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_8C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_9C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_9C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_10C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_10C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_11C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_11C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_12C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_12C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_13C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_13C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_14C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_14C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_15C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_15C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_16C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_16C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_17C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_17C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_18C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_18C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_19C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_19C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_20C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_20C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_21C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_21C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_22C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_22C.mzML SUBJECT_SAMPLE_FACTORS HILIC POS 20250128_FK_23C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250128_FK_23C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-2 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-2.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-4 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-4.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-5 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-5.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-6 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-6.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-10 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-10.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-14 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-14.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-15 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-15.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-17 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-17.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-18 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-18.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-19 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-19.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-20 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-20.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-21 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-21.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-22 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-22.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-23 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-23.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-24 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-24.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-26 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-26.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-27 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-27.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-28 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-28.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-29 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-29.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-30 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-30.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-31 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-31.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-32 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-32.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-33 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-33.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-35 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-35.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1-36 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1-36.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_1C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_1C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_2C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_2C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_3C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_3C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_4C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_4C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_5C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_5C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_6C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_6C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_7C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_7C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_8C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_8C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_9C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_9C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_10C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_10C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_11C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_11C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_12C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_12C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_13C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_13C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_14C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_14C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_15C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_15C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_16C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_16C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_17C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_17C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_18C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_18C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_19C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_19C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_20C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_20C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_21C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_21C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_22C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_22C.mzML SUBJECT_SAMPLE_FACTORS HILIC NEG 20250319_FK_23C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250319_FK_23C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_2C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_2C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_3C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_3C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_4C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_4C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_6C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_6C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_7C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_7C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_9C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_9C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_10C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_10C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_12C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_12C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_13C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_13C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_15C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_15C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_16C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_16C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_17C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_17C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_18C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_18C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_19C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_19C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_20C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_20C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_21C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_21C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_22C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_22C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_23C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_23C.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-5 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-5.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-6 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-6.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-10 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-10.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-14 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-14.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-15 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-15.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-17 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-17.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-18 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-18.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-20 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-20.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-21 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-21.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-22 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-22.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-23 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-23.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-24 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-24.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-26 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-26.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-27 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-27.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-28 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-28.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-29 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-29.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-30 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-30.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-31 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-31.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-32 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-32.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-33 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-33.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-34 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-34.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-35 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-35.mzML SUBJECT_SAMPLE_FACTORS RP POS 20250604_FK_POS_1-36 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250604_FK_POS_1-36.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_2C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_2C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_3C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_3C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_4C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_4C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_6C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_6C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_7C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_7C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_9C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_9C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_10C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_10C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_12C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_12C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_13C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_13C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_15C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_15C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_16C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_16C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_17C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_17C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_18C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_18C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_19C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_19C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_20C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_20C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_21C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_21C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_22C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_22C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_23C Group:HC | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_23C.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-5 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-5.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-6 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-6.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-10 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-10.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-14 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-14.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-15 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-15.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-17 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-17.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-18 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-18.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-20 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-20.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-21 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-21.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-22 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-22.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-23 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-23.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-24 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-24.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-25 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-25.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-26 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-26.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-27 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-27.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-28 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-28.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-29 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-29.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-30 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-30.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-31 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-31.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-32 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-32.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-33 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-33.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-34 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-34.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-35 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-35.mzML SUBJECT_SAMPLE_FACTORS RP NEG 20250611_FK_NEG_1-36 Group:Untreated | Sample source:Plasma RAW_FILE_NAME(Raw file)=20250611_FK_NEG_1-36.mzML #COLLECTION CO:COLLECTION_SUMMARY A total of 50 plasma samples were collected: 24 samples from healthy controls CO:COLLECTION_SUMMARY (non-CF subjects) and 26 plasma samples from untreated individuals with CF. CO:COLLECTION_SUMMARY After collection, plasma samples were stored at -80°C. CO:SAMPLE_TYPE Blood (plasma) CO:STORAGE_CONDITIONS -80℃ #TREATMENT TR:TREATMENT_SUMMARY After collection, plasma samples were stored at -80°C. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY For metabolomic sample preparation, 100 µL of MeOH was added into 100 µl of SP:SAMPLEPREP_SUMMARY plasma sample for protein precipitation. After vortex for 30 seconds and SP:SAMPLEPREP_SUMMARY centrifugation at 13 000 g for 10 minutes, the supernatant was evaporated and SP:SAMPLEPREP_SUMMARY reconstituted in 200 µL of (ACN: H2O) (85:15). A pooled quality control (QC) SP:SAMPLEPREP_SUMMARY was prepared by mixing 10 µL of each sample before injection. For lipidomic SP:SAMPLEPREP_SUMMARY analysis, extraction of plasma lipids was carried out using Matyash modified SP:SAMPLEPREP_SUMMARY protocol using a liquid-liquid extraction method. Fifty µL of plasma was SP:SAMPLEPREP_SUMMARY combined with 600 µL of MTBE and 200 µL of MeOH.11-18 The mixture was vortexed SP:SAMPLEPREP_SUMMARY for 30 seconds to ensure thorough mixing. The samples were afterwards incubated SP:SAMPLEPREP_SUMMARY for 20 minutes at 15°C with continuous agitation at 300 rpm. After incubation, SP:SAMPLEPREP_SUMMARY 180 µL of water was added to the mixture. The plasma samples were vortexed for SP:SAMPLEPREP_SUMMARY 30 seconds to ensure homogeneity. Subsequently, the plasma samples were SP:SAMPLEPREP_SUMMARY centrifuged at 15 000×g for 10 minutes to separate the phases. One hundred µL SP:SAMPLEPREP_SUMMARY of the upper organic phase was carefully collected and evaporated under a stream SP:SAMPLEPREP_SUMMARY of nitrogen to remove the solvent completely. The dried residue was then SP:SAMPLEPREP_SUMMARY reconstituted in 200 µL of MeOH. A pooled quality control (QC) was prepared by SP:SAMPLEPREP_SUMMARY mixing 10 µL of each sample before injection. SP:PROCESSING_STORAGE_CONDITIONS Room temperature SP:EXTRACT_STORAGE -80℃ #CHROMATOGRAPHY CH:CHROMATOGRAPHY_TYPE HILIC CH:INSTRUMENT_NAME Acquity UPLC waters CH:COLUMN_NAME Waters ACQUITY UPLC BEH HILIC (100 x 2.1mm,1.7um) CH:SOLVENT_A 5 mM NH4COOH in H2O:ACN (90:10)+0.1 % FA CH:SOLVENT_B 5 mM NH4COOH in ACN:H2O (90:10)+ 0.1 % FA CH:FLOW_GRADIENT 0-3 min → 100% B 3-8 min → 100 to 20% B 8-10 min → 100 to 40% B 10-13 CH:FLOW_GRADIENT min→ 100% B 13-20 min →100% B CH:FLOW_RATE 0.3 mL/min CH:COLUMN_TEMPERATURE 40°C #ANALYSIS AN:ANALYSIS_TYPE MS #MS MS:INSTRUMENT_NAME Waters Synapt G2 XS QTOF MS:INSTRUMENT_TYPE QTOF MS:MS_TYPE ESI MS:ION_MODE POSITIVE MS:MS_COMMENTS To ensure mass reproducibility and accuracy, leucine-enkephalin was used as the MS:MS_COMMENTS lock mass for positive ion mode (556.2771 [M+H]+) and negative ion mode MS:MS_COMMENTS (554.2615[M-H]-). The concentration was 0.2 ng/mL, the flow rate was 20 μL/min, MS:MS_COMMENTS and the lock-spray frequency was 10 s. The Q-TOF-MSE acquisition was performed MS:MS_COMMENTS in MSE continuum mode under both positive (ESI+) and negative (ESI−) MS:MS_COMMENTS electrospray ionization conditions and data collected were processed by MassLynx MS:MS_COMMENTS and Progenesis QI softwares (Waters Corp.). The capillary voltage was set at 3.0 MS:MS_COMMENTS kV for positive mode and 2.4 kV for negative mode, with a source offset of 80 V. MS:MS_COMMENTS The source temperature was maintained at 120°C, while the desolvation MS:MS_COMMENTS temperature was set at 350°C. Cone gas and desolvation gas were delivered at MS:MS_COMMENTS flow rates of 20 L/h and 800 L/h, respectively. For mass spectrometry MS:MS_COMMENTS acquisition, a low collision energy of 6 eV was applied, whereas during MSE MS:MS_COMMENTS acquisition, a ramped collision energy ranging from 20 to 45 eV was used to MS:MS_COMMENTS generate fragment ions. The full scan mass range was set from m/z 100 to 1200. MS:MS_RESULTS_FILE ST004266_AN007099_Results.txt UNITS:intensity Has m/z:Yes Has RT:Yes RT units:Minutes #END